Insights

analyst-color

3 min read • July 19, 2021

Cantor Fitzgerald Lowers Price Target As Canadian Cannabis Producer Organigram Posts Q3 Earnings

3 min read • June 18, 2021

Cantor Updates Ratings On Several Cannabis And CBD Stocks – MedMen, Jushi, cbdMD, CV Sciences

4 min read • June 9, 2021

California Cannabis Co. Plus Products, Vibe Cannabis Have Unnoticed Upside Potential Claims Viridian Capital Advisors

3 min read • May 17, 2021

US Cannabis Legislation Update: ‘SAFE Act Gaining Steam’

2 min read • May 13, 2021

Cantor Remains ‘Overweight’ On Trulieve Cannabis Post Q1 Earnings, Praises Florida Operations

2 min read • May 11, 2021

Analyst: Cannabis Co. Curaleaf Could Easily Reach Its Full-Year Sales Targets Of $1.3 Billion

2 min read • April 22, 2021

Why This Organigram Analyst Says It’s A Good Time To Buy Cannabis Stock

2 min read • April 10, 2021

Cannabis Analyst: March Earning Season May Not Push Canadian LPs, But There Are Other Catalysts

2 min read • March 23, 2021

Analyst: Massachusetts Cannabis Store Count ‘Is Growing Faster Than Sales’

2 min read • March 18, 2021

Sundial Analyst: Cannabis Stock In A ‘Transition Phase’ Due To M&A Potential, Cost-Cutting Efforts

1 min read • February 22, 2021

UPDATE: Cowen Says Continues To Believe New York Likely To Enact Adult-Use Cannabis Legalization In 2021, Sees Odds Of Final Passage Of Adult-Use Legislation In Virginia For 2021 Below 50%

1 min read • February 22, 2021

Hearing Cowen Sees Cannabis-Related Sales In State Of New Jersey Beginning ‘Sometime Between Jul. 1, 2021 And Jan. 1, 2022’

Latest Headlines

View All

3 min read • September 1, 2026

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

8 min read • September 1, 2026

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

2 min read • September 1, 2026

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

3 min read • September 1, 2026

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

13 min read • September 1, 2026

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

Browse By Channels

Broad U.S. Equity ETFs

first quarter earnings

illegal cannabis farms

intoxicating hemp-derived products

Macro Economic Events

Market-Moving Exclusives

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

View Insights

Secure Access

analyst-color

Cantor Fitzgerald Lowers Price Target As Canadian Cannabis Producer Organigram Posts Q3 Earnings

Cantor Updates Ratings On Several Cannabis And CBD Stocks – MedMen, Jushi, cbdMD, CV Sciences

California Cannabis Co. Plus Products, Vibe Cannabis Have Unnoticed Upside Potential Claims Viridian Capital Advisors

US Cannabis Legislation Update: ‘SAFE Act Gaining Steam’

Cantor Remains ‘Overweight’ On Trulieve Cannabis Post Q1 Earnings, Praises Florida Operations

Analyst: Cannabis Co. Curaleaf Could Easily Reach Its Full-Year Sales Targets Of $1.3 Billion

Why This Organigram Analyst Says It’s A Good Time To Buy Cannabis Stock

Cannabis Analyst: March Earning Season May Not Push Canadian LPs, But There Are Other Catalysts

Analyst: Massachusetts Cannabis Store Count ‘Is Growing Faster Than Sales’

Sundial Analyst: Cannabis Stock In A ‘Transition Phase’ Due To M&A Potential, Cost-Cutting Efforts

UPDATE: Cowen Says Continues To Believe New York Likely To Enact Adult-Use Cannabis Legalization In 2021, Sees Odds Of Final Passage Of Adult-Use Legislation In Virginia For 2021 Below 50%

Hearing Cowen Sees Cannabis-Related Sales In State Of New Jersey Beginning ‘Sometime Between Jul. 1, 2021 And Jan. 1, 2022’

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

USCR Urges Congress to Keep the Hemp Loophole Closed

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

Browse By Channels

Join the Cannabis Revolution

Insights

Insights Tips